1.1 本标准旨在与缉获药物分析的一般要求（实践）结合使用 E2326 , E2327 , E2329 和 E2549 ; 指南 E2548 和 E2329 ). 本标准提供了与可疑秘密药物实验室有关的物品和样品的化学分析指南。本标准为秘密药物实验室证据的分析提供了一般指导，并不能替代详细且经验证的实验室政策和技术程序。 1.2 本标准不能取代通过教育、培训和经验获得的知识、技能或能力（见实践） E2326 )并与具有此类纪律的个人的专业判断一起使用- 特定的知识、技能和能力。 1.3 本标准并非旨在解决与其使用相关的所有安全问题（如有）。本标准的用户有责任在使用前制定适当的安全、健康和环境实践，并确定监管限制的适用性。 1.4 本国际标准是根据世界贸易组织技术性贸易壁垒（TBT）委员会发布的《关于制定国际标准、指南和建议的原则的决定》中确立的国际公认标准化原则制定的。 ====意义和用途====== 4.1 分析员应通过既定的实验室培训，了解秘密药物实验室合成路线和相关样本分析中使用的技术。获得的秘密药物实验室样本知识有助于分析员选择最佳分析方案，以识别试剂、前体、中间体和最终产品。 4.2 与常规缉获毒品分析相比，对秘密毒品实验室证据的定性和定量分析可能需要不同的方法。分析员应了解其定性和定量分析中使用的程序的局限性。这些因素包括方法选择性、不确定性以及从样本到总体的推断基础。 4.3 实验室管理层应确保通过相关程序、文献和实践经验提供秘密药物实验室合成和分析培训。实际经验通常包括秘密药物实验室训练样本的制作、采样和分析。 4.4 实验室管理层应确保化学品安全和卫生计划解决并减轻与秘密药物实验室证据相关的危险。 4.5 它不涉及场景考勤或场景处理。 4.6 实验室管理层应考虑影响这些建议应用的客户/当地要求。

1.1 This standard is intended to be used in conjunction with the general requirements for the analysis of seized drugs (Practices E2326 , E2327 , E2329 , and E2549 ; Guides E2548 and E2329 ). This standard provides guidance on the chemical analysis of items and samples related to suspected clandestine drug laboratories. This standard provides general guidance for the analysis of clandestine drug laboratory evidence and is not a substitute for detailed and validated laboratory policies and technical procedures. 1.2 This standard cannot replace knowledge, skills, or abilities acquired through education, training, and experience (see Practice E2326 ) and is to be used in conjunction with professional judgment by individuals with such discipline-specific knowledge, skills, and abilities. 1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.4 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee. ====== Significance And Use ====== 4.1 An analyst should be knowledgeable, through established laboratory training, of clandestine drug laboratory synthetic routes and the techniques used in the analysis of related samples. This acquired knowledge of clandestine drug laboratory samples assists the analyst in choosing the best analytical scheme to identify reagents, precursors, intermediates, and final products. 4.2 The qualitative and quantitative analyses of clandestine drug laboratory evidence can require different approaches relative to routine seized drug analyses. Analysts shall understand the limitations of the procedures used in their qualitative and quantitative analyses. These include such factors as method selectivity, uncertainty, and the basis for inferences from a sample(s) to a population. 4.3 Laboratory management shall ensure that clandestine drug laboratory synthesis and analysis training be provided through relevant procedures, literature, and practical experience. Practical experience typically includes production, sampling and analysis of clandestine drug laboratory training samples. 4.4 Laboratory management shall ensure that chemical safety and hygiene plans address and mitigate hazards associated with clandestine drug laboratory evidence. 4.5 It does not address scene attendance or scene processing. 4.6 Laboratory management shall consider customer/local requirements which influence the application of these recommendations.